We are live on ! Find out more
LAB icon

Standard BioTools
LAB

100 hedge funds and large institutions have $941M invested in Standard BioTools in 2013 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 37 increasing their positions, 32 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

85% more capital invested

Capital invested by funds: $509M → $941M (+$431M)

79% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 14

32% more call options, than puts

Call options by funds: $10.1M | Put options by funds: $7.66M

16% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 32

12% more funds holding

Funds holding: 89 → 100 (+11)

Holders
100
Holders Change
+11
Holders Change %
+12.36%
% of All Funds
2.9%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
25
Increased
37
Reduced
32
Closed
14
Calls
$10.1M
Puts
$7.66M
Net Calls
+$2.46M
Net Calls Change
+$2.17M

Top Buyers

1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$22M
2
NCGI
Next Century Growth Investors
Minnesota
+$16.3M
3
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$14.1M
4
SCM
Sandler Capital Management
New York
+$10.2M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.84M

Top Sellers

1
Jennison Associates
Jennison Associates
New York
-$20M
2
Primecap Management
Primecap Management
California
-$8.35M
3
FCM
Frontier Capital Management
Massachusetts
-$7M
4
VAM
Visium Asset Management
New York
-$6.62M
5
JP Morgan Chase
JP Morgan Chase
New York
-$6.36M
Name Holding Trade Value Shares
Change 		Change in
Stake
Primecap Management
1
Primecap Management
California
$133M -$8.35M -283,500 -8%
Jennison Associates
2
Jennison Associates
New York
$103M -$20M -679,712 -20%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$67.2M +$8.84M +300,000 +21%
WA
4
Wasatch Advisors
Utah
$66M -$581K -19,723 -1%
Lord, Abbett & Co
5
Lord, Abbett & Co
New Jersey
$63.6M +$22M +746,046 +82%
JP Morgan Chase
6
JP Morgan Chase
New York
$55.7M -$6.36M -215,970 -13%
O
7
OrbiMed
New York
$55.4M +$866K +29,400 +2%
NCGI
8
Next Century Growth Investors
Minnesota
$45.1M +$16.3M +553,183 +89%
BFA
9
BlackRock Fund Advisors
California
$28.1M -$4.2M -142,571 -16%
Vanguard Group
10
Vanguard Group
Pennsylvania
$26M +$3.13M +106,191 +19%
Invesco
11
Invesco
Georgia
$19.1M +$1.51M +51,376 +11%
Loomis, Sayles & Company
12
Loomis, Sayles & Company
Massachusetts
$18.4M +$14.1M +480,165 New
CCM
13
Cupps Capital Management
Illinois
$16.1M +$4.73M +160,649 +62%
State Street
14
State Street
Massachusetts
$15.9M -$264K -8,951 -2%
Northern Trust
15
Northern Trust
Illinois
$14.2M +$465K +15,790 +4%
SCM
16
Sandler Capital Management
New York
$13.2M +$10.2M +345,700 New
CAM
17
Cortina Asset Management
Wisconsin
$12.9M -$254K -8,636 -3%
PC
18
Pier Capital
Connecticut
$12.6M -$468K -15,881 -5%
BIT
19
BlackRock Institutional Trust
California
$11.8M -$566K -19,210 -6%
RIM
20
RS Investment Management
California
$10.7M +$8.25M +280,092 New
Schroder Investment Management Group
21
Schroder Investment Management Group
United Kingdom
$10.6M -$5.48M -185,900 -40%
FA
22
Friess Associates
Delaware
$9.09M +$6.08M +206,458 +666%
Millennium Management
23
Millennium Management
New York
$6.73M +$1.29M +43,759 +33%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$6.66M +$896K +30,421 +21%
CCS
25
Crosspoint Capital Strategies
California
$6.15M +$3.8M +128,983 New
1
2 3 4 5

LAB Hedge Fund Activity: Q4 2013 in Review

100 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q4 2013, worth a combined $941M — up 85% from $509M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new LAB positions and 14 closed out — a net gain of 11 holders — while 37 added to existing stakes and 32 trimmed.

The largest buyer was Lord, Abbett & Co, adding an estimated $22M. The largest seller was Jennison Associates, cutting an estimated $20M.

  • 100 institutional investors held Standard BioTools (LAB) as of Q4 2013, up from 89 in Q3 2013.
  • Funds reported $941M of Standard BioTools stock for Q4 2013, up 85% quarter-over-quarter.
  • 25 funds opened new Standard BioTools positions in Q4 2013 and 14 closed out, a net change of +11 holders.
  • The largest Standard BioTools buyer in Q4 2013 was Lord, Abbett & Co, an estimated $22M added.
  • The largest Standard BioTools seller in Q4 2013 was Jennison Associates, an estimated $20M sold.

Based on aggregated 13F filings for Q4 2013.